The NIHR Brain Injury MedTech Co-operative provides a “go-to” centre of expertise for understanding the Acquired or Traumatic Brain injury care pathway and for the development of medical technologies to support prevention and improving patient outcomes.
The NIHR Brain Injury MedTech Co-operative aims to:
- Find: Identify areas of unmet need throughout the brain injury pathways that might be amenable of a technology-based innovation.
- Facilitate: Promote the generation of innovative solutions through the facilitation of interdisciplinary communication and collaboration between the NHS, academia, industry and public organisations.
- Foster: Support the translational pathway of viable solutions from initial concept to successful market adoption and sustainable clinical impact.
The NIHR Brain Injury MedTech Co-operative is one of the eleven MedTech Co-operative and In Vitro Diagnostic (MICs) funded by the NIHR across the country. The MICs facilitate collaboration with patients, carers, NHS, charities, academia, inventors, SMEs, business angels and medtech companies. The MICs catalyse innovation in clinical areas of unmet needs for NHS patients and is committed to develop new concepts, demonstrate proof of principle and devise research protocols for medical devices, healthcare technologies and technology dependent interventions.
The NIHR Brain Injury MIC will build on the significant achievement of the NIHR Brain Injury Healthcare Technology Co-operative (HTC), 2013-2018. The MICs are here to support SMEs/start-up to access the wider NIHR, get in touch directly to find out more.